Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer

NCT04722718 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin

Sponsor

Jiuda Zhao